Many stars have joined forces with their children on the big and small screen. From Carrie Fisher and Billie Lourd to Eugene ...

Meredith Alloway's Forbidden Fruits joins the horror genre as an instant cult classic through its unique aesthetic.

The FDA approved a GLP-1 pill from Eli Lilly called Foundayo. Foundayo isn't as effective as Lilly's weekly shot Zepbound, but the once-daily pill could be attractive for people looking for ...

Eli Lilly has gone big in the name of neuroscience, paying $6.3 billion in a front-loaded deal for Centessa Pharmaceuticals and its sleep disorder pipeline. In recent years, U.K.-based Centessa has ...

CNBC reported that under the agreement, Insilico will receive $115 million up front, with additional payments tied to regulatory approvals and commercial milestones, as well as royalties on future ...

No Kings protests are kicking off across the Bay Area as part of a nationwide day of action against President Trump's administration. Follow live updates.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

GREAT GIVER (Kuldeep Singh), EXPRESS TRAIN (Apprentice), RED HOT PUNCH (P Ajeeth Kumar) and TRUE ICON (Deepak Singh) in in 1-1s; (600m) 46s., in in 1-16s; 800 58s; (600m) 43s. The former was ...

Matthew Herper covers medical innovation — both its promise and its perils. Eli Lilly will pay up to $2.4 billion to acquire Orna Therapeutics, a biotechnology firm that is developing a technology to ...

With three Big Pharma collaborations already under its belt, Flagship Pioneering spinout Repertoire Immune Medicines has picked up another—and its biggest yet—in a further validation of the company’s ...

In an interview with Bloomberg News, Eli Lilly Chief Financial Officer Lucas Montarce said that the Indiana-based pharma giant remains on track for a potential FDA approval of its obesity pill, ...

Eli Lilly (LLY) achieved 54% year-over-year revenue growth to $17.6B in Q3. Tirzepatide is projected as the top-selling drug by 2030. Lilly raised its quarterly dividend 15% to $1.73 per share. The ...